GOSS Gossamer Bio, Inc.
Healthcare$0.22+4.71%ClosedMarket Cap: $51.6M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$0.77
Target (Median)
$1.00
Target Range
$0.30 - $1.00
Upside from current price: 248.5%
Rating Distribution
1 Strong Buy2 Buy5 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-19 | Barclays | maintain | Underweight | Underweight |
| 2026-03-23 | Cantor Fitzgerald | downgrade | Neutral | Overweight |
| 2026-03-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-05 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-02-24 | Barclays | downgrade | Underweight | Overweight |
| 2026-02-24 | Wedbush | downgrade | Neutral | Outperform |
| 2026-02-24 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2026-01-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-11 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-09-10 | UBS | upgrade | Buy | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.11 | $52.5M | 5 |
| Sun Dec 31 | $0.03 | $131.8M | 5 |
| Mon Dec 31 | $0.19 | $241.6M | 1 |
| Tue Dec 31 | $0.26 | $353.3M | 1 |